These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31744053)

  • 1. RAF Kinase Inhibitor Protein in Myeloid Leukemogenesis.
    Zebisch A; Caraffini V; Sill H
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31744053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of RAF kinase inhibitor protein is involved in myelomonocytic differentiation and aggravates RAS-driven myeloid leukemogenesis.
    Caraffini V; Geiger O; Rosenberger A; Hatzl S; Perfler B; Berg JL; Lim C; Strobl H; Kashofer K; Schauer S; Beham-Schmid C; Hoefler G; Geissler K; Quehenberger F; Kolch W; Athineos D; Blyth K; Wölfler A; Sill H; Zebisch A
    Haematologica; 2020; 105(2):375-386. PubMed ID: 31097632
    [No Abstract]   [Full Text] [Related]  

  • 3. Frequent loss of RAF kinase inhibitor protein expression in acute myeloid leukemia.
    Zebisch A; Wölfler A; Fried I; Wolf O; Lind K; Bodner C; Haller M; Drasche A; Pirkebner D; Matallanas D; Rath O; Blyth K; Delwel R; Taskesen E; Quehenberger F; Kolch W; Troppmair J; Sill H
    Leukemia; 2012 Aug; 26(8):1842-9. PubMed ID: 22388727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of RAF kinase inhibitor protein is a somatic event in the pathogenesis of therapy-related acute myeloid leukemias with C-RAF germline mutations.
    Zebisch A; Haller M; Hiden K; Goebel T; Hoefler G; Troppmair J; Sill H
    Leukemia; 2009 Jun; 23(6):1049-53. PubMed ID: 19357705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Expression of miR-23a Mediates a Loss of Expression in the RAF Kinase Inhibitor Protein RKIP.
    Hatzl S; Geiger O; Kuepper MK; Caraffini V; Seime T; Furlan T; Nussbaumer E; Wieser R; Pichler M; Scheideler M; Nowek K; Jongen-Lavrencic M; Quehenberger F; Wölfler A; Troppmair J; Sill H; Zebisch A
    Cancer Res; 2016 Jun; 76(12):3644-54. PubMed ID: 27197200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor.
    Granovsky AE; Rosner MR
    Cell Res; 2008 Apr; 18(4):452-7. PubMed ID: 18379591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive- and negative-feedback regulations coordinate the dynamic behavior of the Ras-Raf-MEK-ERK signal transduction pathway.
    Shin SY; Rath O; Choo SM; Fee F; McFerran B; Kolch W; Cho KH
    J Cell Sci; 2009 Feb; 122(Pt 3):425-35. PubMed ID: 19158341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of Raf kinase inhibitor protein (RKIP) in multiple cancer types.
    Lamiman K; Keller JM; Mizokami A; Zhang J; Keller ET
    Crit Rev Oncog; 2014; 19(6):455-68. PubMed ID: 25597355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.
    Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR
    Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells.
    Lee HC; Tian B; Sedivy JM; Wands JR; Kim M
    Gastroenterology; 2006 Oct; 131(4):1208-17. PubMed ID: 17030190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
    Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raf kinase inhibitor protein (RKIP) in cancer.
    Escara-Wilke J; Yeung K; Keller ET
    Cancer Metastasis Rev; 2012 Dec; 31(3-4):615-20. PubMed ID: 22684368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raf kinase inhibitor protein regulation of raf and MAPK signaling.
    Hagan S; Garcia R; Dhillon A; Kolch W
    Methods Enzymol; 2006; 407():248-59. PubMed ID: 16757329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raf kinase inhibitor RKIP inhibits MDA-9/syntenin-mediated metastasis in melanoma.
    Das SK; Bhutia SK; Sokhi UK; Azab B; Su ZZ; Boukerche H; Anwar T; Moen EL; Chatterjee D; Pellecchia M; Sarkar D; Fisher PB
    Cancer Res; 2012 Dec; 72(23):6217-26. PubMed ID: 23066033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raf kinase inhibitor protein1 is a myogenic inhibitor with conserved function in avians and mammals.
    Coulton G; Hou Y; Mirczuk SM; Allen SP
    Dev Dyn; 2016 Sep; 245(9):902-12. PubMed ID: 27240024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RKIP: a governor of intracellular signaling.
    Lorenz K; Schmid E; Deiss K
    Crit Rev Oncog; 2014; 19(6):489-96. PubMed ID: 25597358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raf kinase inhibitor protein (RKIP) dimer formation controls its target switch from Raf1 to G protein-coupled receptor kinase (GRK) 2.
    Deiss K; Kisker C; Lohse MJ; Lorenz K
    J Biol Chem; 2012 Jul; 287(28):23407-17. PubMed ID: 22610096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biology of a prostate cancer metastasis suppressor protein: Raf kinase inhibitor protein.
    Keller ET; Fu Z; Brennan M
    J Cell Biochem; 2005 Feb; 94(2):273-8. PubMed ID: 15565643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol binds and activates RKIP protein in colorectal cancer.
    Dariya B; Behera SK; Srivani G; Aliya S; Alam A; Nagaraju GP
    Amino Acids; 2020 Sep; 52(9):1299-1306. PubMed ID: 32918615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Raf kinase inhibitor protein (RKIP) in health and disease.
    Keller ET; Fu Z; Brennan M
    Biochem Pharmacol; 2004 Sep; 68(6):1049-53. PubMed ID: 15313400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.